Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Clinical Trials

Roche to Present New New OCREVUS data at ECTRIMS advance clinical understanding of underlying progression in multiple sclerosis

Clinical Trials
Roche announced that new OCREVUS® data are being presented at the 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) –...

BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn® in ALS

Clinical Trials
BrainStorm Cell Therapeutics Inc announced that the first patients have been enrolled in the Phase 3 clinical trial of NurOwn® for the treatment of...

Seattle Genetics and Astellas Initiate Pivotal Trial of Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer

Clinical Trials
Seattle Genetics, Inc. and Astellas Pharma Inc. announced dosing of the first patient in EV-201, a registrational phase 2 clinical trial of enfortumab vedotin...

Exelixis Provides Update on Collaborator Daiichi Sankyo’s Phase 3 Clinical Progress with Esaxerenone

Clinical Trials
Exelixis, Inc. announced that its partner Daiichi Sankyo Company, Limited (“Daiichi Sankyo”) has reported positive top-line results from a phase 3 pivotal trial of...

Novartis’ Cosentyx sets new benchmark in psoriasis with robust 5-year sustained phase III efficacy & safety data

Clinical Trials
Novartis announced, first of its kind phase III data showing Cosentyx (secukinumab) delivered high and long-lasting skin clearance in patients with moderate-to-severe plaque psoriasis...

Dr Reddy’s Labs subsidiary Aurigene and Curis to initiate phase 2 trial of PDL1-VISTA inhibitor ‘CA-170’ in India

Clinical Trials
Aurigene Discovery Technologies Ltd, a wholly owned subsidiary of Dr. Reddy’s Laboratories Ltd and Curis, Inc. have announced plans to initiate a Phase 2...

GSK announces phase III results published in NEJM of mepolizumab in patients with eosinophilic COPD at risk of exacerbations

Clinical Trials
GlaxoSmithKline plc, announced the publication of full results from the phase III studies for mepolizumab in chronic obstructive pulmonary disease (COPD). Data from the...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

Whitepapers 0
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 0
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 0
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.